O
ALXN
OrbiMed’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-150,900
| Closed | -$27.7M | – | 185 |
|
|
2021
Q2 | $27.7M | Buy |
150,900
+48,800
| +48% | +$8.97M | 0.28% | 85 |
|
|
2021
Q1 | $15.6M | Sell |
102,100
-66,900
| -40% | -$10.2M | 0.15% | 106 |
|
|
2020
Q4 | $26.4M | Sell |
169,000
-2,015,500
| -92% | -$315M | 0.23% | 88 |
|
|
2020
Q3 | $250M | Buy |
2,184,500
+28,500
| +1% | +$3.26M | 3.14% | 4 |
|
|
2020
Q2 | $242M | Buy |
2,156,000
+84,615
| +4% | +$9.5M | 3.41% | 3 |
|
|
2020
Q1 | $186M | Buy |
2,071,385
+408,800
| +25% | +$36.7M | 3.13% | 6 |
|
|
2019
Q4 | $180M | Sell |
1,662,585
-700
| -0% | -$75.7K | 2.57% | 8 |
|
|
2019
Q3 | $163M | Sell |
1,663,285
-262,800
| -14% | -$25.7M | 3.09% | 7 |
|
|
2019
Q2 | $252M | Sell |
1,926,085
-31,115
| -2% | -$4.08M | 3.91% | 4 |
|
|
2019
Q1 | $265M | Sell |
1,957,200
-90,200
| -4% | -$12.2M | 4.1% | 4 |
|
|
2018
Q4 | $199M | Sell |
2,047,400
-833,703
| -29% | -$81.2M | 3.69% | 6 |
|
|
2018
Q3 | $401M | Sell |
2,881,103
-243,500
| -8% | -$33.8M | 4.82% | 1 |
|
|
2018
Q2 | $388M | Sell |
3,124,603
-143,672
| -4% | -$17.8M | 4.63% | 1 |
|
|
2018
Q1 | $364M | Buy |
3,268,275
+388,700
| +13% | +$43.3M | 4.52% | 1 |
|
|
2017
Q4 | $344M | Sell |
2,879,575
-765,911
| -21% | -$91.6M | 4.36% | 2 |
|
|
2017
Q3 | $511M | Sell |
3,645,486
-226,300
| -6% | -$31.7M | 4.89% | 1 |
|
|
2017
Q2 | $471M | Buy |
3,871,786
+160,800
| +4% | +$19.6M | 4.94% | 1 |
|
|
2017
Q1 | $450M | Buy |
3,710,986
+322,600
| +10% | +$39.1M | 5.1% | 1 |
|
|
2016
Q4 | $415M | Buy |
3,388,386
+750,375
| +28% | +$91.8M | 5.28% | 1 |
|
|
2016
Q3 | $323M | Sell |
2,638,011
-343,400
| -12% | -$42.1M | 3.68% | 4 |
|
|
2016
Q2 | $348M | Buy |
2,981,411
+1,110,811
| +59% | +$130M | 3.63% | 6 |
|
|
2016
Q1 | $260M | Sell |
1,870,600
-404,500
| -18% | -$56.3M | 2.74% | 10 |
|
|
2015
Q4 | $434M | Buy |
2,275,100
+48,500
| +2% | +$9.25M | 3.93% | 8 |
|
|
2015
Q3 | $348M | Buy |
2,226,600
+182,200
| +9% | +$28.5M | 3.52% | 9 |
|
|
2015
Q2 | $370M | Buy |
2,044,400
+1,478,700
| +261% | +$267M | 3.09% | 9 |
|
|
2015
Q1 | $98M | Buy |
565,700
+233,700
| +70% | +$40.5M | 0.84% | 37 |
|
|
2014
Q4 | $61.4M | Buy |
332,000
+20,000
| +6% | +$3.7M | 0.59% | 43 |
|
|
2014
Q3 | $51.7M | Hold |
312,000
| – | – | 0.54% | 44 |
|
|
2014
Q2 | $48.8M | Buy |
312,000
+45,000
| +17% | +$7.03M | 0.57% | 45 |
|
|
2014
Q1 | $40.6M | Buy |
267,000
+34,100
| +15% | +$5.19M | 0.5% | 46 |
|
|
2013
Q4 | $30.9M | Buy |
232,900
+17,000
| +8% | +$2.26M | 0.45% | 49 |
|
|
2013
Q3 | $25.1M | Buy |
215,900
+23,000
| +12% | +$2.67M | 0.45% | 48 |
|
|
2013
Q2 | $17.8M | Buy |
+192,900
| New | +$17.8M | 0.38% | 49 |
|